HRS-5041
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for HRS-5041, covering 2024-12-18 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer [Phase 1]